THE ROLE OF THE “RIFIZOSTREP” PREPARATION IN THE PREVENTION OF BOVINE TUBERCULOSIS VETERINARY RESEARCH INSTITUTE TUBERCULOSIS LABORATORY

Abstract

In order to determine the effectiveness of the drug “Rifizostrep” in the treatment of tuberculosis, a series of experiments were conducted. As a result, on March 18, 2024, in the presence of the commission members, four calves in Group 1 were infected with M. bovis-149, and three calves each in Groups 2 and 3 were infected with the M. tuberculosis strain. After infection, Groups 1 and 2 received subcutaneous injections of the Rifizostrep preparation in the neck area once every 10 days according to the Methodological Guidelines. Group 3 served as the control group; after infection with M. tuberculosis-7880, no treatment was administered. As a result, when tuberculin testing was performed on the animals infected with M. bovis-149 and M. tuberculosis-7880 and treated with Rifizostrep (Groups 1 and 2), negative reactions were observed. In contrast, in the control group (Group 3), infected with M. tuberculosis-7880 but not treated with antibiotics, positive tuberculin reactions were recorded.